REYON Pharmaceutical Statistics
Total Valuation
KRX:102460 has a market cap or net worth of KRW 206.15 billion. The enterprise value is 406.36 billion.
Market Cap | 206.15B |
Enterprise Value | 406.36B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KRX:102460 has 18.34 million shares outstanding.
Current Share Class | 18.34M |
Shares Outstanding | 18.34M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 81.15% |
Owned by Institutions (%) | 3.15% |
Float | 2.96M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.37 |
PB Ratio | 0.87 |
P/TBV Ratio | 0.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -41.62 |
EV / Sales | 2.71 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -36.78 |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.88.
Current Ratio | 0.61 |
Quick Ratio | 0.34 |
Debt / Equity | 0.88 |
Debt / EBITDA | 67.33 |
Debt / FCF | -18.90 |
Interest Coverage | -2.22 |
Financial Efficiency
Return on equity (ROE) is -4.04% and return on invested capital (ROIC) is -2.33%.
Return on Equity (ROE) | -4.04% |
Return on Assets (ROA) | -2.20% |
Return on Invested Capital (ROIC) | -2.33% |
Return on Capital Employed (ROCE) | -4.94% |
Revenue Per Employee | 341.03M |
Profits Per Employee | -22.19M |
Employee Count | 440 |
Asset Turnover | 0.31 |
Inventory Turnover | 2.65 |
Taxes
In the past 12 months, KRX:102460 has paid 2.12 billion in taxes.
Income Tax | 2.12B |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.43% in the last 52 weeks. The beta is 0.69, so KRX:102460's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -10.43% |
50-Day Moving Average | 11,446.20 |
200-Day Moving Average | 11,995.60 |
Relative Strength Index (RSI) | 64.07 |
Average Volume (20 Days) | 13,050 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:102460 had revenue of KRW 150.05 billion and -9.76 billion in losses. Loss per share was -533.00.
Revenue | 150.05B |
Gross Profit | 55.30B |
Operating Income | -17.03B |
Pretax Income | -7.64B |
Net Income | -9.76B |
EBITDA | 3.10B |
EBIT | -17.03B |
Loss Per Share | -533.00 |
Balance Sheet
The company has 8.64 billion in cash and 208.85 billion in debt, giving a net cash position of -200.21 billion or -10,915.98 per share.
Cash & Cash Equivalents | 8.64B |
Total Debt | 208.85B |
Net Cash | -200.21B |
Net Cash Per Share | -10,915.98 |
Equity (Book Value) | 236.97B |
Book Value Per Share | 12,920.07 |
Working Capital | -50.58B |
Cash Flow
In the last 12 months, operating cash flow was -1.82 billion and capital expenditures -9.23 billion, giving a free cash flow of -11.05 billion.
Operating Cash Flow | -1.82B |
Capital Expenditures | -9.23B |
Free Cash Flow | -11.05B |
FCF Per Share | -602.42 |
Margins
Gross margin is 36.85%, with operating and profit margins of -11.35% and -6.51%.
Gross Margin | 36.85% |
Operating Margin | -11.35% |
Pretax Margin | -5.09% |
Profit Margin | -6.51% |
EBITDA Margin | 2.07% |
EBIT Margin | -11.35% |
FCF Margin | n/a |
Dividends & Yields
KRX:102460 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -4.74% |
FCF Yield | -5.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.02.
Last Split Date | Dec 29, 2020 |
Split Type | Forward |
Split Ratio | 1.02 |
Scores
KRX:102460 has an Altman Z-Score of 1.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.24 |
Piotroski F-Score | 3 |